| PDF (670kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-314123
- DOI to cite this document:
- 10.5283/epub.31412
Abstract
Background: Hemangioblastomas (HBLs) are benign neoplasms that contribute to 1-2.5% of intracranial tumors and 7-12% of posterior fossa lesions in adult patients. HBLs either evolve hereditarily in association with von Hippel-Lindau disease (vHL) or, more prevalently, as solitary sporadic tumors. Only few authors have reported on the clinical presentation and the neurological outcome of HBL. ...

Owner only: item control page